OFIX(OFIX)
OFIX
ANALYST COVERAGE17 analysts
HOLD
▲ +48.1%upside to target
Key MetricsTTM
Market Cap$491.12M
Revenue TTM$825.37M
Net Income TTM-$60.01M
Free Cash Flow-$3.63M
Gross Margin69.0%
Operating Margin-4.0%
Net Margin-7.3%
Return on Equity-13.4%
Return on Assets-6.8%
Debt / Equity0.54
Current Ratio2.87
EPS TTM$-1.48
PRICE
Prev Close
12.09
Open
12.27
Day Range11.97 – 12.34
11.97
12.34
52W Range10.24 – 16.99
10.24
16.99
28% of range
VOLUME & SIZE
Avg Volume
302.3K
FUNDAMENTALS
P/E Ratio
-8.1x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
0.78
Low vol
TECHNICAL
RSI (14)
39
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 22
DEx-Dividend
In 90 days
Aug 19
PDividend Pay
In 96 days
Aug 25
OFIX News
About
Orthofix Medical Inc. is a global medical device and biologics company with a spine and extremities focus. The Company's mission is to deliver innovative, quality-driven solutions as it partners with health care professionals to improve patients' lives. Headquartered in Lewisville, Texas, Orthofix's spine and orthopedic extremities products are distributed in more than 70 countries via the Company's sales representatives and distributors.
Beau StandishChief Enabling Technologies Officer
Geoffrey C. GillespieChief Accounting Officer
J. Andres CedronChief Legal Officer & Corporate Secretary
Lucas S. VitaleChief People & Business Operations Officer
Massimo CalafiorePresident, Chief Executive Officer & Director
Max ReinhardtPresident of the Global Spine Business
Patrick FisherPresident of Global Biologics & Limb Reconstruction
Aviva McPherronPresident of Global Operations & Quality
Jill MasonChief Compliance & Risk Officer
Julie AndrewsChief Financial Officer
Julie D. DeweyChief Investor Relations & Communications Officer
Stephanie WalshChief Human Resources Officer